From: Unexpected drug residuals in human milk in Ankara, capital of Turkey
Breast milk residue | Maternal antibiotic usage during postpartum period | Overall | P for residue | P for maternal self-use | Interaction between residue and self-use | ||
---|---|---|---|---|---|---|---|
Absence | Presence | ||||||
Maternal BMI change after birtha | |||||||
Polymyxin | – | −2.53 ± 0.40 | −0.15 ± 0.48 | −1.34 ± 0.30 | 0.764 | 0.004 | 0.962 |
Polymyxin | + | −2.81 ± 1.08 | −0.36 ± 1.09 | −1.59 ± 0.77 | |||
Overall | −2.67 ± 0.57 | −0.26 ± 0.59 | |||||
Infant’s WAZb | |||||||
Polymyxin | – | −0.20 ± 0.15 | 0.18 ± 0.17 | −0.01 ± 0.11 | 0.525 | 0.176 | 0.920 |
Polymyxin | + | −0.42 ± 0.39 | 0.02 ± 0.39 | −0.20 ± 0.27 | |||
Overall | −0.31 ± 0.21 | 0.10 ± 0.21 | |||||
Maternal BMI change (kg/m2) after birtha | |||||||
Aminoglycoside | – | −2.72 ± 0.45 | −0.39 ± 0.53 | −1.55 ± 0.34 | 0.364 | < 0.001 | 0.889 |
Aminoglycoside | + | −2.23 ± 0.67 | 0.27 ± 0.79 | −0.98 ± 0.52 | |||
Overall | −2.47 ± 0.40 | −0.06 ± 0.47 | |||||
Infant’s WAZb | |||||||
Aminoglycoside | – | −0.17 ± 0.16 | 0.17 ± 0.20 | 0.00 ± 0.13 | 0.585 | 0.067 | 0.751 |
Aminoglycoside | + | −0.36 ± 0.25 | 0.12 ± 0.25 | −0.12 ± 0.18 | |||
Overall | −0.26 ± 0.15 | 0.15 ± 0.16 |